Acumen Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-18.0M | $-18.0M | $40.0K | $922.0K |
| FY2022 | $-35.2M | $-35.3M | $161.0K | $3.1M |
| FY2023 | $-43.1M | $-43.1M | $21.0K | $6.1M |
| FY2024 | $-86.2M | $-86.2M | $16.0K | $9.6M |
| FY2025 | $-115.5M | $-115.6M | $88.0K | $9.9M |